Merck & Co Inc
(FRA:6MK)
€
92.9
-0.2 (-0.21%)
Market Cap: 236.96 Bil
Enterprise Value: 261.27 Bil
PE Ratio: 21.36
PB Ratio: 5.93
GF Score: 78/100 
Merck & Co Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020 / 12:30AM GMT
Release Date Price:
€76.66
(+0.50%)
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott from JPMorgan. I'm very pleased to be hosting Merck today. From the company, we have Ken Frazier, Chairman and CEO; as well as Roger Perlmutter, President of Merck Research Labs.
First of all, Happy New Year, and thanks for joining us.
Kenneth C. Frazier
Merck & Co., Inc. - Chairman, President & CEO
Happy New Year to you, Chris, and thanks for having us.
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
Yes, we're going to be doing a fireside chat format. And like prior years, we're not going to be doing a breakout afterwards, so we'll just do the chat and then break from there.
Questions & Answers
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst
So maybe Ken to open up and just help us set the stage for the conversation. Can you talk a
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers